JP2022539329A5 - - Google Patents
Info
- Publication number
- JP2022539329A5 JP2022539329A5 JP2021576479A JP2021576479A JP2022539329A5 JP 2022539329 A5 JP2022539329 A5 JP 2022539329A5 JP 2021576479 A JP2021576479 A JP 2021576479A JP 2021576479 A JP2021576479 A JP 2021576479A JP 2022539329 A5 JP2022539329 A5 JP 2022539329A5
- Authority
- JP
- Japan
- Prior art keywords
- body weight
- days
- approximately
- compound
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/092675 | 2019-06-25 | ||
| CN2019092675 | 2019-06-25 | ||
| PCT/CN2020/097881 WO2020259528A1 (zh) | 2019-06-25 | 2020-06-24 | 治疗特发性肺纤维化的方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022539329A JP2022539329A (ja) | 2022-09-08 |
| JP2022539329A5 true JP2022539329A5 (cg-RX-API-DMAC7.html) | 2023-06-29 |
| JP7615061B2 JP7615061B2 (ja) | 2025-01-16 |
Family
ID=74061495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576479A Active JP7615061B2 (ja) | 2019-06-25 | 2020-06-24 | 特発性肺線維症を治療する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12582653B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3992183B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7615061B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN114026072A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020305979B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021026214A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3144113A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL289192B1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI804743B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020259528A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118772118A (zh) * | 2020-08-31 | 2024-10-15 | 北京泰德制药股份有限公司 | Rho相关蛋白激酶抑制剂的盐、其固体形式及其制备方法和用途 |
| CA3209240A1 (en) * | 2021-02-22 | 2022-08-25 | Samuel D. Waksal | Rock2 inhibitor for the treatment of viral infection |
| NO346587B1 (en) * | 2021-06-02 | 2022-10-17 | Axichem Ab | Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis |
| TW202327608A (zh) * | 2021-09-17 | 2023-07-16 | 北京泰德製藥股份有限公司 | 治療病毒感染的方法 |
| CA3231781A1 (en) * | 2021-09-18 | 2023-03-23 | Beijing Tide Pharmaceutical Co., Ltd. | Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereof |
| EP4434513A4 (en) * | 2021-11-16 | 2025-11-19 | Beijing Tide Pharmaceutical Co Ltd | NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND ITS PREPARATION PROCESS |
| US20250074908A1 (en) * | 2022-01-13 | 2025-03-06 | Wuhan Createrna Science And Technology Co., Ltd. | Salt of rock inhibitor, crystal form of salt, composition, and pharmaceutical use |
| TW202423441A (zh) * | 2022-10-13 | 2024-06-16 | 大陸商北京泰德製藥股份有限公司 | 治療塵肺病的方法 |
| WO2025017500A1 (en) | 2023-07-17 | 2025-01-23 | Graviton Bioscience Bv | Formulations of rock2 inhibitors for cns disorders |
| AU2024292342A1 (en) | 2023-07-17 | 2026-02-26 | Graviton Bioscience Bv | Formulations and uses of rock2 inhibitors for als |
| IL327381A (en) | 2023-09-28 | 2026-05-01 | Graviton Pharmaceuticals B V | Treatment for type 1 diabetes using ROCK2 and DYRK1 inhibitors |
| IL327385A (en) | 2023-09-29 | 2026-05-01 | Graviton Pharmaceuticals B V | ROCK2 inhibitors in the treatment of obesity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018506571A (ja) | 2015-02-27 | 2018-03-08 | リセラ・コーポレイションLycera Corporation | Rho関連プロテインキナーゼの阻害及び疾患の治療のためのインダゾリルチアジアゾールアミン及び関連する化合物 |
| TWI800498B (zh) * | 2016-12-21 | 2023-05-01 | 義大利商吉斯藥品公司 | 作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物 |
| JP7311228B2 (ja) * | 2017-06-30 | 2023-07-19 | ベイジン タイド ファーマシューティカル カンパニー リミテッド | Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用 |
| US10329282B2 (en) | 2017-06-30 | 2019-06-25 | Beijing Tide Pharmaceutical Co., Ltd. | Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof |
-
2020
- 2020-06-24 TW TW109121568A patent/TWI804743B/zh active
- 2020-06-24 AU AU2020305979A patent/AU2020305979B2/en active Active
- 2020-06-24 CN CN202080045478.XA patent/CN114026072A/zh active Pending
- 2020-06-24 WO PCT/CN2020/097881 patent/WO2020259528A1/zh not_active Ceased
- 2020-06-24 IL IL289192A patent/IL289192B1/en unknown
- 2020-06-24 US US17/621,719 patent/US12582653B2/en active Active
- 2020-06-24 BR BR112021026214A patent/BR112021026214A2/pt unknown
- 2020-06-24 EP EP20833444.1A patent/EP3992183B1/en active Active
- 2020-06-24 CA CA3144113A patent/CA3144113A1/en active Pending
- 2020-06-24 JP JP2021576479A patent/JP7615061B2/ja active Active
- 2020-06-24 CN CN202510159677.8A patent/CN119868365A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522486A5 (cg-RX-API-DMAC7.html) | ||
| AU2024202105B2 (en) | Inhibitors of (alpha-v)(beta-6) integrin | |
| CN115190815B (zh) | 芳基环己基胺衍生物及其在精神障碍的治疗中的用途 | |
| JP2020125355A (ja) | 併用療法 | |
| NZ788543A (en) | Dimethyltryptamine derivatives and their use in psychedelic-assisted psychotherapy | |
| JP4708708B2 (ja) | プルロムチリン誘導体を使用する結核症治療 | |
| JP6745726B2 (ja) | 中枢神経系障害の処置における2,4−チアゾリジンジオン誘導体 | |
| EP2959903B1 (en) | Medicine for treating eye disease | |
| JP2010501565A (ja) | Bclタンパク質と結合パートナーとの相互作用を阻害する化合物および方法 | |
| JP2022539329A (ja) | 特発性肺線維症を治療する方法 | |
| CA2921621C (en) | Quinine compounds, and optical isomers, preparation method and medical use thereof | |
| JP2012525437A5 (cg-RX-API-DMAC7.html) | ||
| WO2021060453A1 (ja) | 架橋型光学活性2級アミン誘導体 | |
| JP2017522304A5 (cg-RX-API-DMAC7.html) | ||
| JP7508620B2 (ja) | ジヒドロクロメン誘導体 | |
| JP2023535035A5 (cg-RX-API-DMAC7.html) | ||
| EP3760616A1 (en) | 4-methyldihydropyrimidinone compound and medicinal use thereof | |
| CZ285633B6 (cs) | Použití indolových derivátů pro výrobu léčiv a farmaceutický prostředek | |
| TW202304914A (zh) | 經取代之四環羧酸、其類似物及使用其之方法 | |
| JP2022531570A5 (cg-RX-API-DMAC7.html) | ||
| JP2022530890A5 (cg-RX-API-DMAC7.html) | ||
| JP2025504447A5 (cg-RX-API-DMAC7.html) | ||
| RU2013149416A (ru) | Производные камптотецина, обладающие противоопухолевой активностью | |
| KR20180054826A (ko) | Hiv 성숙 억제 활성을 갖는 화합물 | |
| WO2023041024A1 (zh) | 治疗病毒感染的方法 |